Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: M...
FDA Drug Recall #D-1271-2020 — Class II — May 5, 2020
Recall Summary
| Recall Number | D-1271-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 5, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Mylan Institutional LLC |
| Location | Rockford, IL |
| Product Type | Drugs |
| Quantity | 3,010 vials |
Product Description
Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50
Reason for Recall
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
Distribution Pattern
Distributed Nationwide in the USA
Lot / Code Information
Lot #: Lot N1700771, EXP October 2020; Lot N1800127, EXP February 2021
Other Recalls from Mylan Institutional LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0601-2021 | Class III | Thiamine HCl Injection, USP 200 mg/2 mL (100mg/... | May 3, 2021 |
| D-1576-2020 | Class I | Tranexamic Acid Injection, USP, 1000 mg/10 mL (... | Aug 17, 2020 |
| D-1575-2020 | Class I | Amiodarone Hydrochloride Injection, USP, 450 mg... | Aug 17, 2020 |
| D-1484-2020 | Class I | Daptomycin for Injection, 500 mg/vial, Single-D... | Jul 7, 2020 |
| D-1329-2015 | Class I | Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 ... | Apr 23, 2015 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.